Abstract:In the author's institution, 2254 patients with hepatocellular carcinoma (HCC) have been treated during 1958-1994. The overall 5-year survival increased from 5.4% (1958-1970), to 11.9% (1971-1982), to 46.2% (1983-1984), which correlated well with the increasing proportion of small HCC in the series (2.6%, 12.1%, and 33.4%, respectively); with the increasing percentage of limited resection (3.1%, 32.2%, and 58.3%); with the increasing number of re-resections for recurrence (0, 27, and 114 patients); and with the increasing number of second stage resections (0, 5, and 67 patients). In our institution, surgical approaches that resulted in significantly prolonging survival included: small HCC resection, re-resection, and cytoreduction followed by sequential resection for initially unresectable HCC. Experience in these 3 aspects suggests: (a) Small HCCs are mainly found by screening using AFP and ultrasonography (US) in a high risk population, and limited resection is the best treatment in patients with compensated liver cirrhosis, the 5-year survival after resection being 62.9% (n = 549). (b) Postoperative monitoring using AFP/US every 2-3 months for 5-10 years after curative resection is needed to detect subclinical recurrence. Limited re-resection is indicated for liver recurrence less than 3 nodules, and lung lobectomy is of proven merit to prolong survival for solitary lung metastasis. Re-resection of subclinical recurrence has resulted in a 10-20% further increase in 5-year survival after curative resection. (c) Palliative surgery other than resection such as hepatic artery ligation (HAL) and cannulation with arterial infusion (HAI), cryosurgery, etc. are superior to palliative resection with residual cancer. (d) Cytoreduction and sequential resection have provided hope for localized unresectable HCC, particularly in the right cirrhotic liver. Multimodality combination treatments such as HAL+HAI+radioimmunotherapy/regional radiotherapy are acceptable cytoreductive therapies. Repeated transcatheter hepatic arterial chemoembolization (TACE) is an alternative nonsurgical approach. Sequential resection is important to eradicate residual cancer after cytoreduction. The 5-year survival of 72 patients with cytoreduction and sequential resection for initially unresectable HCC was 62.1% and resulted in improving 5-year survival in the entire series of unresectable HCC over the 3 periods from 0% to 7.4% to 25.7%, respectively. However, multicentric origin and tumor invasiveness are two major targets to be studied in the control of recurrence and metastasis.

Serial Therapies Oriented by Surgery for Large Primary Liver Carcinoma.

A Surgery Oriented Serial Treatments of 191 Patients with Large Primary Liver Cancer

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Surgical Resection Plus Radiofrequency Ablation for the Treatment of Multifocal Hepatocellular Carcinoma.

[Multi-Modal Serial Therapy for Primary Liver Cancer in Senile Patients: a Report of 153 Cases].

Surgical Treatments of Primary Liver Cancer Patients with Severe Cirrhosis: a Report of 78 Cases CHEN

Experience with Liver Resection after Hepatic Arterial Chemoembolization for Hepatocellular Carcinoma.

Multimodality Treatment in Advanced Primary Liver Cancer.

Systematic sequential therapy for ex vivo liver resection and autotransplantation: A case report and review of literature

Three Decades' Experience In Surgery Of Hepatocellular Carcinoma

Surgery for Primary Liver Cancer: A Forty Years Survey

[Results of Multimodality Therapy for Unresectable Primary Liver Cancer].

Results of Liver Resection for Primary Liver Cancer

Evaluation of Surgical Approach for Extrahepatic Cholangiocarcinoma.

Surgery of Small Hepatocellular-Carcinoma - Analysis of 144 Cases

Diagnosis and Treatment of Hepatic Cholangiocarcinoma: Report of 52 Cases.

Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection

Hepatic Artery Ligation and Infusion Chemotherapy for Unresectable Primary Liver Cancer.

[Current approaches to surgical treatment of liver tumors]